What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q4 2018?

154 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 81,089,428
Share change: +40,263,309
Total reported value: $448,181,562
Put/Call ratio: 29%
Price per share: $5.53
Number of holders: 154
Value change: +$214,692,780
Number of buys: 116
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	2%	5,268,846	$46,523,000	—	30 Sep 2018	13F
Nantahala Capital Management, LLC	13F	Company	1.8%	4,724,211	$41,715,000	—	30 Sep 2018	13F
Novo Holdings A/S	13F	Company	1.2%	3,100,000	$27,373,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	0.97%	2,557,583	$22,583,000	—	30 Sep 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.93%	2,449,521	$21,629,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	0.87%	2,281,142	$20,143,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.72%	1,887,436	$16,666,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.68%	1,776,971	$15,691,000	—	30 Sep 2018	13F
ABRAMS CAPITAL MANAGEMENT, L.P.	13F	Company	0.43%	1,119,286	$9,883,000	—	30 Sep 2018	13F
Clearbridge Investments, LLC	13F	Company	0.39%	1,016,526	$8,976,000	—	30 Sep 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	991,776	$8,758,000	—	30 Sep 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.3%	801,366	$7,076,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	0.26%	674,878	$5,959,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	637,950	$5,633,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.24%	634,396	$5,601,000	—	30 Sep 2018	13F
DAFNA Capital Management LLC	13F	Company	0.24%	625,738	$5,525,000	—	30 Sep 2018	13F
Marshall Wace North America L.P.	13F	Company	0.22%	580,549	$5,126,000	—	30 Sep 2018	13F
MARSHALL WACE, LLP	13F	Company	0.2%	539,064	$4,760,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.18%	485,750	$4,289,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	0.18%	475,000	$4,194,000	—	30 Sep 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.17%	453,627	$4,006,000	—	30 Sep 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.16%	409,833	$3,619,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.14%	358,520	$3,165,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	349,622	$3,088,000	—	30 Sep 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.13%	330,452	$2,918,000	—	30 Sep 2018	13F
Man Group plc	13F	Company	0.12%	306,119	$2,703,000	—	30 Sep 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	305,693	$2,699,000	—	30 Sep 2018	13F
Rubric Capital Management LP	13F	Company	0.12%	302,731	$2,673,000	—	30 Sep 2018	13F
Stanley-Laman Group, Ltd.	13F	Company	0.11%	301,182	$2,659,000	—	30 Sep 2018	13F
Spark Investment Management LLC	13F	Company	0.11%	300,000	$2,649,000	—	30 Sep 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.11%	298,212	$2,633,000	—	30 Sep 2018	13F
Tekla Capital Management LLC	13F	Company	0.1%	266,612	$2,354,000	—	30 Sep 2018	13F
OMERS ADMINISTRATION Corp	13F	Company	0.1%	259,830	$2,294,000	—	30 Sep 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	257,452	$2,273,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.08%	215,026	$1,898,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.07%	173,735	$1,534,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0.06%	159,797	$1,411,000	—	30 Sep 2018	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	156,266	$1,380,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	142,937	$1,262,000	—	30 Sep 2018	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.05%	134,533	$1,188,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	123,625	$1,092,000	—	30 Sep 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	104,971	$927,000	—	30 Sep 2018	13F
ALPS ADVISORS INC	13F	Company	0.04%	100,948	$891,000	—	30 Sep 2018	13F
Laurion Capital Management LP	13F	Company	0.04%	99,321	$877,000	—	30 Sep 2018	13F
BARCLAYS PLC	13F	Company	0.04%	95,045	$839,000	—	30 Sep 2018	13F
Squarepoint Ops LLC	13F	Company	0.03%	84,863	$749,000	—	30 Sep 2018	13F
SG Americas Securities, LLC	13F	Company	0.03%	79,629	$703,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	78,637	$694,000	—	30 Sep 2018	13F
Swiss National Bank	13F	Company	0.03%	78,100	$690,000	—	30 Sep 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	77,672	$686,000	—	30 Sep 2018	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2018

As of 31 Dec 2018, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,089,428 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Nantahala Capital Management, LLC, Vanguard Group Inc, Novo Holdings A/S, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, CITADEL ADVISORS LLC, and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 154 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

126

Q4 2018 holders

154

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.